5-amino-1mq and cd38 inhibitor synergy nad+ Selective membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice Nicotinamide N-Methyltransferase in Cardiovascular Diseases:
Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target Discovery of a First in Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy Journal of Medicinal Chemistry NAD+ metabolism and its roles in cellular processes during ageing PMC Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening
Pay in 4 interest-free payments of $6.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3


